Cargando…

Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand

BACKGROUND: Shiga toxin-producing Escherichia coli (STEC) is an important cause of bloody diarrhoea (BD), non-bloody diarrhoea (NBD) and the haemolytic uraemic syndrome (HUS). In Argentina and New Zealand, the most prevalent STEC serotype is O157:H7, which is responsible for the majority of HUS case...

Descripción completa

Detalles Bibliográficos
Autores principales: Leotta, Gerardo A, Miliwebsky, Elizabeth S, Chinen, Isabel, Espinosa, Estela M, Azzopardi, Kristy, Tennant, Sharon M, Robins-Browne, Roy M, Rivas, Marta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2277424/
https://www.ncbi.nlm.nih.gov/pubmed/18366637
http://dx.doi.org/10.1186/1471-2180-8-46
_version_ 1782152027568078848
author Leotta, Gerardo A
Miliwebsky, Elizabeth S
Chinen, Isabel
Espinosa, Estela M
Azzopardi, Kristy
Tennant, Sharon M
Robins-Browne, Roy M
Rivas, Marta
author_facet Leotta, Gerardo A
Miliwebsky, Elizabeth S
Chinen, Isabel
Espinosa, Estela M
Azzopardi, Kristy
Tennant, Sharon M
Robins-Browne, Roy M
Rivas, Marta
author_sort Leotta, Gerardo A
collection PubMed
description BACKGROUND: Shiga toxin-producing Escherichia coli (STEC) is an important cause of bloody diarrhoea (BD), non-bloody diarrhoea (NBD) and the haemolytic uraemic syndrome (HUS). In Argentina and New Zealand, the most prevalent STEC serotype is O157:H7, which is responsible for the majority of HUS cases. In Australia, on the other hand, STEC O157:H7 is associated with a minority of HUS cases. The main aims of this study were to compare the phenotypic and genotypic characteristics of STEC O157 strains isolated between 1993 and 1996 from humans in Argentina, Australia and New Zealand, and to establish their clonal relatedness. RESULTS: Seventy-three O157 STEC strains, isolated from HUS (n = 36), BD (n = 20), NBD (n = 10), or unspecified conditions (n = 7) in Argentina, Australia and New Zealand, were analysed. The strains were confirmed to be E. coli O157 by biochemical tests and serotyping. A multiplex polymerase chain reaction (PCR) was used to amplify the stx(1), stx(2 )and rfb(O157 )genes and a genotyping method based on PCR-RFLP was used to determine stx(1 )and stx(2 )variants. This analysis revealed that the most frequent stx genotypes were stx(2)/stx(2c (vh-a) )(91%) in Argentina, stx(2 )(89%) in New Zealand, and stx(1)/stx(2 )(30%) in Australia. No stx(1)-postive strains were identified in Argentina or New Zealand. All strains harboured the eae gene and 72 strains produced enterohaemolysin (EHEC-Hly). The clonal relatedness of strains was investigated by phage typing and pulsed-field gel electrophoresis (PFGE). The most frequent phage types (PT) identified in Argentinian, Australian, and New Zealand strains were PT49 (n = 12), PT14 (n = 9), and PT2 (n = 15), respectively. Forty-six different patterns were obtained by XbaI-PFGE; 37 strains were grouped in 10 clusters and 36 strains showed unique patterns. Most clusters could be further subdivided by BlnI-PFGE. CONCLUSION: STEC O157 strains isolated in Argentina, Australia, and New Zealand differed from each other in terms of stx-genotype and phage type. Additionally, no common PFGE patterns were found in strains isolated in the three countries. International collaborative studies of the type reported here are needed to detect and monitor potentially hypervirulent STEC clones.
format Text
id pubmed-2277424
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22774242008-04-01 Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand Leotta, Gerardo A Miliwebsky, Elizabeth S Chinen, Isabel Espinosa, Estela M Azzopardi, Kristy Tennant, Sharon M Robins-Browne, Roy M Rivas, Marta BMC Microbiol Research Article BACKGROUND: Shiga toxin-producing Escherichia coli (STEC) is an important cause of bloody diarrhoea (BD), non-bloody diarrhoea (NBD) and the haemolytic uraemic syndrome (HUS). In Argentina and New Zealand, the most prevalent STEC serotype is O157:H7, which is responsible for the majority of HUS cases. In Australia, on the other hand, STEC O157:H7 is associated with a minority of HUS cases. The main aims of this study were to compare the phenotypic and genotypic characteristics of STEC O157 strains isolated between 1993 and 1996 from humans in Argentina, Australia and New Zealand, and to establish their clonal relatedness. RESULTS: Seventy-three O157 STEC strains, isolated from HUS (n = 36), BD (n = 20), NBD (n = 10), or unspecified conditions (n = 7) in Argentina, Australia and New Zealand, were analysed. The strains were confirmed to be E. coli O157 by biochemical tests and serotyping. A multiplex polymerase chain reaction (PCR) was used to amplify the stx(1), stx(2 )and rfb(O157 )genes and a genotyping method based on PCR-RFLP was used to determine stx(1 )and stx(2 )variants. This analysis revealed that the most frequent stx genotypes were stx(2)/stx(2c (vh-a) )(91%) in Argentina, stx(2 )(89%) in New Zealand, and stx(1)/stx(2 )(30%) in Australia. No stx(1)-postive strains were identified in Argentina or New Zealand. All strains harboured the eae gene and 72 strains produced enterohaemolysin (EHEC-Hly). The clonal relatedness of strains was investigated by phage typing and pulsed-field gel electrophoresis (PFGE). The most frequent phage types (PT) identified in Argentinian, Australian, and New Zealand strains were PT49 (n = 12), PT14 (n = 9), and PT2 (n = 15), respectively. Forty-six different patterns were obtained by XbaI-PFGE; 37 strains were grouped in 10 clusters and 36 strains showed unique patterns. Most clusters could be further subdivided by BlnI-PFGE. CONCLUSION: STEC O157 strains isolated in Argentina, Australia, and New Zealand differed from each other in terms of stx-genotype and phage type. Additionally, no common PFGE patterns were found in strains isolated in the three countries. International collaborative studies of the type reported here are needed to detect and monitor potentially hypervirulent STEC clones. BioMed Central 2008-03-17 /pmc/articles/PMC2277424/ /pubmed/18366637 http://dx.doi.org/10.1186/1471-2180-8-46 Text en Copyright © 2008 Leotta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Leotta, Gerardo A
Miliwebsky, Elizabeth S
Chinen, Isabel
Espinosa, Estela M
Azzopardi, Kristy
Tennant, Sharon M
Robins-Browne, Roy M
Rivas, Marta
Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand
title Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand
title_full Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand
title_fullStr Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand
title_full_unstemmed Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand
title_short Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand
title_sort characterisation of shiga toxin-producing escherichia coli o157 strains isolated from humans in argentina, australia and new zealand
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2277424/
https://www.ncbi.nlm.nih.gov/pubmed/18366637
http://dx.doi.org/10.1186/1471-2180-8-46
work_keys_str_mv AT leottagerardoa characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand
AT miliwebskyelizabeths characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand
AT chinenisabel characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand
AT espinosaestelam characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand
AT azzopardikristy characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand
AT tennantsharonm characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand
AT robinsbrowneroym characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand
AT rivasmarta characterisationofshigatoxinproducingescherichiacolio157strainsisolatedfromhumansinargentinaaustraliaandnewzealand